Though many physicians are reluctant to change the status quo, a study published in JAMA Internal Medicine Feb. 4 suggests automated office blood pressure measurement (AOBP) is the way to go when recording a patient’s BP, since the approach bypasses the so-called “white coat effect” triggered by more traditional methods.

There’s not much aging individuals can do to beat back age-related cognitive impairment once it begins, but improving consistency in blood pressure seems to help slow the pace of the falloff in those with significant BP swings.

A 73-year-old Florida man posing as a fake doctor was arrested after he diagnosed an undercover cop with diabetes and high cholesterol and offered to “cure” the man with a $2,000 autologous blood transfusion, the Miami Herald reported Feb. 13.

“Rather than bringing in many additional statin candidates, this testing should serve as a decision aid to ‘de-risk’ certain patients and distinguish those who may benefit from preventive pharmacologic therapies," Johns Hopkins researchers wrote in the Annals of Internal Medicine.

A capsule no bigger than a blueberry could be the future of insulin delivery for type 1 diabetics, according to researchers at MIT.

ProvideGx, a subsidiary of Premier, will begin its offerings with metoprolol, a beta-blocker that can treat blood pressure and angina and is commonly given to heart attack patients.

Fast-acting, inhalable insulin is growing in popularity among American adults with diabetes, local Minnesota outlet Fox 9 reported Feb. 1.

Statin therapy reduces the risk of major cardiovascular events across all age ranges, even among people older than 75, according to a meta-analysis published in The Lancet.